SCHEMBL5610334

SCHEMBL5610334

Cc1c(OCC(C)O)cn2ncnc(Oc3cnc4c(c3)=CC(C)N=4)c12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 11/20 0.64
▸ CYP3A4 P08684 6/20 0.51
▸ FGFR1 P11362 5/20 0.51
▸ KCNH2 Q12809 2/20 0.51
▸ STK10 O94804 2/20 0.51
▸ MAP4K4 O95819 2/20 0.51
▸ RET P07949 2/20 0.51
▸ PDGFRB P09619 2/20 0.51
▸ DDR1 Q08345 2/20 0.51
▸ SLK Q9H2G2 2/20 0.51
▸ EPHB6 O15197 1/20 0.51
▸ RIPK2 O43353 1/20 0.51
▸ ABL1 P00519 1/20 0.51
▸ EGFR P00533 1/20 0.51
▸ LCK P06239 1/20 0.51
▸ CSF1R P07333 1/20 0.51
▸ HCK P08631 1/20 0.51
▸ KIT P10721 1/20 0.51
▸ SRC P12931 1/20 0.51
▸ PDGFRA P16234 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5610324 1.00 KDR (0.64) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL5610331 0.79 KDR (0.63) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL1683487 0.78 KDR (1.00) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL1683484 0.78 KDR (1.00) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL5794122 0.75 KDR (0.62) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL5795253 0.75 KDR (0.62) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL5610419 0.72 KDR (0.62) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL5610412 0.72 KDR (0.62) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL14111448 0.70 KDR (0.84) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL1683436 0.70 KDR (1.00) KDRCYP3A4FGFR1KCNH2STK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539763-A4 AZAINDOLE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2007-08-01 — — EP disclosed
EP-1539763-A1 AZAINDOLE KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2005-06-15 — — EP disclosed
WO-2004009601-A1 AZAINDOLE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-01-29 — — WO disclosed
Send feedback